P373 Effect of risankizumab on improved and sustained...

Journal of Crohn's and Colitis 2019 / 01 Vol. 13; Iss. Supplement

P373 Effect of risankizumab on improved and sustained quality of life in patients with moderate to severe Crohn’s disease: Phase 2 trial results

Louis, E, Sandborn, W J, D’Haens, G, Baert, F, Kalabic, J, Wallace, K, Lee, W-J, Feagan, B G
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.497
Date:
January, 2019
File:
PDF, 1.62 MB
2019
Conversion to is in progress
Conversion to is failed